Q Therapeutics, Inc. 5
5 · Q Therapeutics, Inc. · Filed Aug 13, 2013
Insider Transaction Report
Form 5
Q Therapeutics, Inc.[NONE]
EPPSTEIN DEBORAH ANNE
CEO & President, Director
Transactions
- Award
Options to Purchase Common Stock
2012-03-28$1.00/sh+250,000$250,000→ 1,647,477 totalExercise: $1.00From: 2012-03-28Exp: 2022-03-27→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Granted options to purchase common stock subject to vesting. Options were 3/48 vested immediately upon grant, with vesting spread evenly over the remaining 45 months.